Zealand Pharma A/S Statistics
Share Statistics
Zealand Pharma A/S has 0
shares outstanding. The number of shares has increased by -0.6%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.6% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -5.26 and the forward
PE ratio is null.
Zealand Pharma A/S's PEG ratio is
-0.26.
| PE Ratio | -5.26 |
| Forward PE | n/a |
| PS Ratio | 18.3 |
| Forward PS | n/a |
| PB Ratio | 5.77 |
| P/FCF Ratio | -4.34 |
| PEG Ratio | -0.26 |
Financial Ratio HistoryEnterprise Valuation
Zealand Pharma A/S has an Enterprise Value (EV) of 5.01B.
| EV / Sales | 17.13 |
| EV / EBITDA | -5.1 |
| EV / EBIT | -4.13 |
| EV / FCF | -4.06 |
Financial Position
The company has a current ratio of 5.15,
with a Debt / Equity ratio of 0.85.
| Current Ratio | 5.15 |
| Quick Ratio | 4.8 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | -0.8 |
| Debt / FCF | -0.64 |
| Interest Coverage | -250.02 |
Financial Efficiency
Return on Equity is -109.74% and Return on Invested Capital is -59.12%.
| Return on Equity | -109.74% |
| Return on Assets | -49.24% |
| Return on Invested Capital | -59.12% |
| Revenue Per Employee | $1,234,459.92 |
| Profits Per Employee | $-4,295,987.34 |
| Employee Count | 237 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 1 |
Taxes
| Income Tax | -8.79M |
| Effective Tax Rate | 0.86% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 1.34, so Zealand Pharma A/S's
price volatility has been higher than the market average.
| Beta | 1.34 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 17.62 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 49.2 |
| Average Volume (20 Days) | 1,758 |
Income Statement
In the last 12 months, Zealand Pharma A/S had revenue of 292.57M
and earned -1.02B
in profits. Earnings per share was -26.54.
| Revenue | 292.57M |
| Gross Profit | 173.75M |
| Operating Income | -1.02B |
| Net Income | -1.02B |
| EBITDA | -982.6M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -26.54 |
Full Income StatementBalance Sheet
The company has 1.13B in cash and 787.43M in
debt, giving a net cash position of 341.67M.
| Cash & Cash Equivalents | 1.13B |
| Total Debt | 787.43M |
| Net Cash | 341.67M |
| Retained Earnings | -3.31B |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -1.21B
and capital expenditures -22.13M, giving a free cash flow of -1.23B.
| Operating Cash Flow | -1.21B |
| Capital Expenditures | -22.13M |
| Free Cash Flow | -1.23B |
| FCF Per Share | -32.16 |
Full Cash Flow StatementMargins
Gross margin is 59.39%, with operating and profit margins of -349.61% and -348.01%.
| Gross Margin | 59.39% |
| Operating Margin | -349.61% |
| Pretax Margin | -351.01% |
| Profit Margin | -348.01% |
| EBITDA Margin | -335.85% |
| EBIT Margin | -349.61% |
| FCF Margin | -421.82% |
